ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

Isoliquiritigenin alleviates radiation-induced intestinal injury in lung cancer by inhibiting TNF-α/caspase3 signaling pathway.

Ya-Ping Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.